PGP and Alzheimer disease: One study demonstrated elevated endogenous Aβ levels in the hippocampal area of P-gp deficient mice indicating reduced clearance, while concurrently, administration of P-gp inhibitors also significantly increased endogenous brain levels in a mouse model of AD, clearly indicating the role of P-gp in the clearance of Aβ [26].